Hematologic Safety Profile of Linezolid in the Early Periengraftment Period after Allogeneic Stem Cell Transplantation

This publication has 12 references indexed in Scilit:

• Colonization, Bloodstream Infection, and Mortality Caused by Vancomycin-Resistant Enterococcus Early after Allogeneic Hematopoietic Stem Cell Transplant
  Transplantation and Cellular Therapy, 2007
• Efficacy and Safety of Linezolid Compared with Vancomycin in a Randomized, Double-Blind Study of Febrile Neutropenic Patients with Cancer
  Clinical Infectious Diseases, 2006
• Pre‐ and post‐engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients
  Transplant Infectious Disease, 2005
• Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course
  Bone Marrow Transplantation, 2005
• Similar Hematologic Effects of Long‐Term Linezolid and Vancomycin Therapy in a Prospective Observational Study of Patients with Orthopedic Infections
  Clinical Infectious Diseases, 2004
• Linezolid Does Not Increase the Risk of Thrombocytopenia in Patients with Nosocomial Pneumonia: Comparative Analysis of Linezolid and Vancomycin Use
  Clinical Infectious Diseases, 2003
• Worldwide Assessment of Linezolid's Clinical Safety and Tolerability: Comparator-Controlled Phase III Studies
  Antimicrobial Agents and Chemotherapy, 2003
• Thrombocytopenia Associated with Linezolid Therapy
  Clinical Infectious Diseases, 2002
• Linezolid-Induced Anemia and Thrombocytopenia
  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2002
• Hematologic Effects of Antimicrobials: Focus on the Oxazolidinone Linezolid
  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2001